Drug Profile
Naproxcinod - Fera/Nicox
Alternative Names: AZD 3582; HCT 3012; Naproxen nitroxybutylester; Nitronaproxen; NO-naproxenLatest Information Update: 03 May 2022
Price :
$50
*
At a glance
- Originator NicOx
- Developer Fera Pharmaceuticals; NicOx
- Class Antirheumatics; Naphthaleneacetic acids; Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Sickle cell anaemia
- No development reported Osteoarthritis
- Discontinued COVID 2019 infections; Duchenne muscular dystrophy